References
- . Shope RE. The incidence of neutralizing antibodies for swine influenza virus in the sera of human beings of different ages. J Exp Med. 1936;63:669–684
- . Crosby A. America's Forgotten Pandemic. The Influenza of 1918. Cambridge, UK: Cambridge University Press; 2003
- . Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis. Lancet. 2006;368(9554):2211–2218
- . Mathews JD, Chesson JM, McCaw JM, McVernon J. Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respi Viruses. 2009;3(4):143–149
- . Belshe RB. The origins of pandemic influenza-lessons from the 1918 virus. N Engl J Med. 2005;353(21):2209–2211
- . Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis. 2006;12(1):29–33
- . Shinde V, Bridges CB, Uyeki TM, . Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med. 2009;360(25):2616–2625
- . Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children–Southern California, March–April 2009. MMWR. 2009;58(15):400–402
- . Belshe RB. Implications of the emergence of a novel H1 influenza virus. N Engl J Med. 2009;360(25):2667–2668
- . Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med. 2009;361(3):225–229
- . Fraser C, Donnelly CA, Cauchemez S, .; WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324(5934):1557–1561
- . Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med. 2009;361(2):115–119
- . Centers for Disease Control and Prevention. H1N1 flu. http://www.cdc.gov/h1n1flu.com. Accessed August 4, 2009
- . Chowell G, Bertozzi SM, Colchero MA, . Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;13;361(7):674–679
- . ; Novel Swine-Origin Influenza A (H1N1) Virus Investigation TeamDawood FS, Jain S, Finelli L, . Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360(25):2605–2615
- . Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school–New York City, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(17):470–472
- . Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection–Michigan, June 2009. MMWR Morb Mortal Wkly Rep. 2009;58(27):749–752
- . Centers for Disease Control and Prevention (CDC). Evaluation of rapid influenza diagnostic testing for detection of novel influenza A (H1N1) virus–United States, August 2009. MMWR Morb Mortal Wkly Rep. 2009;58(30):826–829
- . Centers for Disease Control and Prevention (CDC). Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(16):433–435
- . Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(32):893–896
- . McGeer A, Green KA, Plevneshi A. Shigayeva A, .; Toronto Invasive Bacterial Diseases Network. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45(12):1568–1575
- . ; Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) VirusAbdel-Ghafar AN, Chotpitayasunohdh T, Gao Z, . Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008;358(3):261–273
- . Harper SA, Bradley JS, Englund JA, .; Expert Panel of the Infectious Diseases Society of America. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003–1032
- . Hughes RA, Charlton J, Latinovic R, Gulliford MC. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med. 2006;166(12):1301–1304
- . Sivadon-Tardy V, Orlikowski D, Porcher R, . Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2009;48(1):48–56
- . CIDRAP. ACIP targets up to 159 millionAmericans for H1N1 vaccination. http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/jul2909acip.html. Accessed August 7, 2009
- . Use of influenza A (H1N1) 2009 monovalent vaccine-recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58(RR-10):1–8
- . Zaman K, Roy E, Arifeen SE, . Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555–1564